News

Novo Nordisk's Ozempic Weight Loss Jabs Could Boost UK Economy By $6 Billion, Study Finds
Weight loss drugs like semaglutide could add £4.5 billion to the UK economy annually, boosting productivity and reducing ...
A New Wave of Lawsuits Alleges Ozempic Causes Patients to Go Blind
About a dozen lawsuits, citing 2024 studies, allege Ozempic causes a rare eye disorder that leads to irreversible blindness. ...
Ozempic, other weight loss drugs may be cut from Medi-Cal coverage under Newsom's budget proposal
California is not required by federal law to cover the cost of the weight loss drugs in its Medi-Cal program. Instead, the state opted to include them. Under Newsom’s proposed cuts, when Ozempic is ...
Indianapolis Business Journal10h
Novo Nordisk inks $2.2B deal to develop weight-loss pill to rival Lilly’s orforglipron
Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...
Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers
The company’s blockbuster drugs helped it beat Wall Street’s expectations—while WeightWatchers declares bankruptcy. One day ...
Novo Nordisk shares are rising after the company cut its outlook. It’s been that kind of year.
Novo Nordisk on Wednesday managed the unusual feat of seeing its stock price rise after reducing its earnings outlook. But ...
Novo Nordisk Stock Jumps Despite Full-Year Outlook Cut
U.S.-listed shares of Novo Nordisk are jumping in premarket trading Wednesday even as the Danish pharmaceutical giant lowered ...
Health on MSN1d
Ozempic Shows Promise in Treating a Severe Form of Liver Disease, Study Finds
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...